DE602004031130D1 - Hautregenerationssystem - Google Patents

Hautregenerationssystem

Info

Publication number
DE602004031130D1
DE602004031130D1 DE602004031130T DE602004031130T DE602004031130D1 DE 602004031130 D1 DE602004031130 D1 DE 602004031130D1 DE 602004031130 T DE602004031130 T DE 602004031130T DE 602004031130 T DE602004031130 T DE 602004031130T DE 602004031130 D1 DE602004031130 D1 DE 602004031130D1
Authority
DE
Germany
Prior art keywords
regeneration
culture medium
cell culture
regeneration system
skin regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004031130T
Other languages
English (en)
Inventor
Zee Upton
Damien Harkin
David Leavesley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
Queensland University of Technology QUT
Original Assignee
University of Queensland UQ
Queensland University of Technology QUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ, Queensland University of Technology QUT filed Critical University of Queensland UQ
Publication of DE602004031130D1 publication Critical patent/DE602004031130D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
DE602004031130T 2003-07-28 2004-07-28 Hautregenerationssystem Active DE602004031130D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003903896A AU2003903896A0 (en) 2003-07-28 2003-07-28 Skin regeneration system
PCT/AU2004/001006 WO2005012508A1 (en) 2003-07-28 2004-07-28 Skin regeneration system

Publications (1)

Publication Number Publication Date
DE602004031130D1 true DE602004031130D1 (de) 2011-03-03

Family

ID=31983524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004031130T Active DE602004031130D1 (de) 2003-07-28 2004-07-28 Hautregenerationssystem

Country Status (15)

Country Link
US (1) US8911997B2 (de)
EP (1) EP1664280B1 (de)
JP (2) JP4543036B2 (de)
KR (1) KR101174795B1 (de)
CN (1) CN1829791B (de)
AT (1) ATE496117T1 (de)
AU (1) AU2003903896A0 (de)
CA (1) CA2533422C (de)
DE (1) DE602004031130D1 (de)
DK (1) DK1664280T3 (de)
ES (1) ES2360060T3 (de)
HK (1) HK1091508A1 (de)
NZ (1) NZ544703A (de)
WO (1) WO2005012508A1 (de)
ZA (1) ZA200600815B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101834A1 (en) 2005-03-17 2006-09-28 Stratatech Corporation Skin substitutes with improved purity
US20070004037A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for culturing keratinocytes
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
WO2007019468A2 (en) * 2005-08-05 2007-02-15 Dixon David M Apparatus and method to treat a wound area
WO2007024899A2 (en) * 2005-08-23 2007-03-01 The General Hospital Corporation Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
DE102007040252A1 (de) 2006-09-11 2008-06-12 Gerlach, Jörg, Prof. Dr. Sprühapparat für Zellen und Methode zur Anwendung gesprühter Zellen
CN103865871A (zh) * 2007-06-08 2014-06-18 韦克福里斯特大学健康科学院 治疗肾功能衰竭的选择性细胞疗法
US10590391B2 (en) 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
AU2008295441A1 (en) * 2007-09-04 2009-03-12 Queensland University Of Technology A feeder cell-free culture medium and system
WO2010057015A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
DE102011100450B8 (de) 2011-04-27 2013-10-17 Jörg Gerlach Apparat zum Sprühen von Zellen, Herstellung des Apparates, Methode zum Sprühen mit dem Apparat und eine Zellsuspension gesprüht mit dem Apparat
GB2498700B (en) 2011-07-15 2018-05-09 Bifold Fluidpower Ltd A solenoid-operated valve
RU2499603C1 (ru) * 2012-06-01 2013-11-27 Федеральное государственное бюджетное учреждение "Нижегородский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения и социального развития Российской Федерации Способ лечения глубоких ожогов на ранних этапах
JP2014204711A (ja) * 2013-03-19 2014-10-30 国立大学法人 千葉大学 三次元培養皮膚モデルの製造方法およびその利用
JP6410343B2 (ja) * 2014-07-01 2018-10-24 学校法人順天堂 脂肪組織由来幹細胞から表皮角化細胞への誘導
KR102236977B1 (ko) * 2015-01-23 2021-04-07 (주) 에스바이오메딕스 3차원 섬유아세포집합체 및 그의 생산방법
CN105132358B (zh) * 2015-07-29 2019-12-06 苏州诺普再生医学有限公司 培养获得组织工程表皮的方法及其应用
CN105132357B (zh) * 2015-07-29 2019-12-06 苏州诺普再生医学有限公司 一种用于表皮细胞培养的无血清培养体系
EP3468722B1 (de) 2016-06-14 2022-02-09 RenovaCare Sciences Corp. Modulare vorrichtung für zellsprühen
WO2024024561A1 (ja) * 2022-07-29 2024-02-01 国立研究開発法人国立成育医療研究センター ケラチノサイトを作製する方法、ケラチノサイトを連続培養するための培地キット、及びケラチノサイト

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000569A1 (en) 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US5654267A (en) * 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
US6090790A (en) 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
US5292655A (en) 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
US5834312A (en) 1990-01-29 1998-11-10 Hy-Gene, Inc. Process and media for the growth of human epithelia
ATE189393T1 (de) * 1990-11-20 2000-02-15 Kowa Co Therapeutisches agens zur wundbehandlung
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
AU3192299A (en) 1998-03-18 1999-10-11 Wake Forest University Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
AU758073B2 (en) * 1998-11-09 2003-03-13 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
WO2003102171A1 (en) * 2002-05-28 2003-12-11 Becton, Dickinson And Company Expansion and transdifferentiation of human acinar cells
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth

Also Published As

Publication number Publication date
DK1664280T3 (da) 2011-04-26
ES2360060T3 (es) 2011-05-31
US20060233764A1 (en) 2006-10-19
EP1664280A1 (de) 2006-06-07
CN1829791B (zh) 2011-05-11
EP1664280A4 (de) 2006-11-02
CA2533422A1 (en) 2005-02-10
EP1664280B1 (de) 2011-01-19
JP2007500001A (ja) 2007-01-11
US8911997B2 (en) 2014-12-16
AU2003903896A0 (en) 2003-08-07
ZA200600815B (en) 2007-04-25
CN1829791A (zh) 2006-09-06
NZ544703A (en) 2008-10-31
JP4543036B2 (ja) 2010-09-15
ATE496117T1 (de) 2011-02-15
JP2010057513A (ja) 2010-03-18
KR20060054380A (ko) 2006-05-22
CA2533422C (en) 2012-10-23
KR101174795B1 (ko) 2012-08-17
WO2005012508A1 (en) 2005-02-10
HK1091508A1 (en) 2007-01-19

Similar Documents

Publication Publication Date Title
HK1091508A1 (en) Skin regeneration system
WO2006070370A3 (en) Stem cells culture systems
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
SG152273A1 (en) Pdx1 expressing endoderm
MX2009011805A (es) Mejora de las concentraciones de polipeptido del factor viii en cultivos celulares.
SE0201328D0 (sv) Hematopoietic differentiation of human embryonic stem cells
BRPI0516572A (pt) métodos e composições para melhorar a produção de proteìnas recombinantes
CO5601047A2 (es) Metodo de cultivo celular libre de animal
ATE488600T1 (de) Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion
DK1918364T3 (da) Fremgangsmåde til rekloning af produktionsceller
AU2003304250A1 (en) Method of isolating cells from umbilical cord
GB2446525A (en) Stem cell culture medium and method
WO2005028626A3 (en) Cell culture media
WO2009145419A9 (ko) 식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
DK1201749T3 (da) Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
DE602005002829D1 (de) Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
ATE489456T1 (de) Menschliche hornhautendothelzellen und verfahren zur gewinnung und kultivierung von zellen zur hornhautzelltransplantation
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells
ATE517176T1 (de) Verfahren zur kultivierung von geschmackszellen aus säugern
Salerno et al. MMP13 and TIMP1 are functional markers for two different potential modes of action by mesenchymal stem/stromal cells when treating osteoarthritis
WO2008002329A3 (en) Isolation and expansion of animal cells in cell cultures
WO2004022782A3 (en) Compositions and methods for tissue specific or inducible inhibition of gene expression
WO2002002591A3 (en) Peptides for use in culture media
TW200519209A (en) Culture system and method for expansion and undifferentiated growth of human embryonic stem cells